Resources
Research and resources
The published research behind image-guided, accelerated neuromodulation, and trusted places to learn more.
Treatment in this practice is built on published research. The papers below are a starting point for anyone who wants to read the evidence directly.
These studies tested specific protocols, which may differ from the treatment offered in this practice. Research results describe groups of patients; they do not predict or guarantee any individual's outcome.
Functional-connectivity targeting
- JAMA Psychiatry · 2026Connectivity- vs scalp-based targeting of accelerated transcranial magnetic stimulation for depression: a randomized clinical trialTaylor, Kare, Haj-Darwish, et al. 2026;83(8):807–817.A blinded randomized trial in 40 adults with treatment-resistant depression: depression scores fell further with connectivity-based than with scalp-based targeting. The authors call for a larger confirmatory trial. (opens in a new tab)
- Biological Psychiatry · 2012Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulateFox, Buckner, White, Greicius, Pascual-Leone. 2012;72(7):595–603.Found that the TMS sites that had worked best for depression were those most strongly linked, in opposite directions, to a deep mood-related region — the idea behind connectivity-guided targeting. (opens in a new tab)
- Biological Psychiatry · 2018Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sitesWeigand, Horn, Caballero, et al. 2018;84(1):28–37.Tested that idea in patients: the connectivity of each person's stimulation site predicted how well TMS worked. (opens in a new tab)
- Human Brain Mapping · 2021Personalized connectivity-guided DLPFC-TMS for depression: advancing computational feasibility, precision and reproducibilityCash, Cocchi, Lv, et al. 2021;42(13):4155–4172.Methods for finding a personalized, connectivity-based target reliably in an individual brain. (opens in a new tab)
- Biological Psychiatry · 2019Subgenual functional connectivity predicts antidepressant treatment response to transcranial magnetic stimulation: independent validation and evaluation of personalizationCash, Zalesky, Thomson, Tian, Cocchi, Fitzgerald. 2019;86(2):e5–e7.An independent check of the link between a stimulation site's connectivity and treatment response, and a first look at personalizing the target. (opens in a new tab)
- Biological Psychiatry · 2021Using brain imaging to improve spatial targeting of transcranial magnetic stimulation for depressionCash, Weigand, Zalesky, et al. 2021;90(10):689–700.A review of how imaging is being used to find a more precise target, for everyone and for each individual. (opens in a new tab)
- Biological Psychiatry · 2024Personalized and circuit-based transcranial magnetic stimulation: evidence, controversies, and opportunitiesCash, Zalesky. 2024;95(6):510–522.A review of the case for personalized targets, the open questions, and the need for large prospective trials. (opens in a new tab)
- Nature Reviews Neuroscience · 2022Causal mapping of human brain functionSiddiqi, Kording, Parvizi, Fox. 2022;23(6):361–375.A review of how stimulation and lesion studies show which brain circuits cause symptoms, and how that guides targeting. (opens in a new tab)
Accelerated and theta-burst TMS
- American Journal of Psychiatry · 2020Stanford Accelerated Intelligent Neuromodulation Therapy for treatment-resistant depressionCole, Stimpson, Bentzley, et al. 2020;177(8):716–726.An open-label study of an accelerated, connectivity-guided protocol in 22 people with treatment-resistant depression. (opens in a new tab)
- American Journal of Psychiatry · 2022Stanford Neuromodulation Therapy (SNT): a double-blind randomized controlled trialCole, Phillips, Bentzley, et al. 2022;179(2):132–141.The sham-controlled trial of that protocol, which enrolled 32 participants with treatment-resistant depression. (opens in a new tab)
- The Lancet · 2018Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trialBlumberger, Vila-Rodriguez, Thorpe, et al. 2018;391(10131):1683–1692.A large trial showing that a brief theta-burst session was not inferior to a standard, much longer TMS session. (opens in a new tab)
Enhancing plasticity
For patients and families
- Nonprofit foundationFoundation for the Advancement of Clinical TMS (FACTMS)The charitable foundation of the Clinical TMS Society, working to raise awareness of TMS and widen access to treatment. (opens in a new tab)
- National Institute of Mental HealthBrain stimulation therapiesA plain-language overview of TMS and related treatments. (opens in a new tab)
- Professional societyClinical TMS SocietyThe professional society for clinicians who provide TMS, with information for patients. (opens in a new tab)
Next step
Begin with a conversation.
Requesting a consultation is confidential and carries no obligation. Tell us a little about what brings you here, and we will take it from there.